Grape King Bio Ltd (TPE:1707)
Taiwan · Delayed Price · Currency is TWD 124.50
+0.50 (0.40%)
Oct 23, 2025, 2:36 PM CST
Grape King Bio Market Cap
Grape King Bio has a market cap or net worth of 18.44 billion as of October 24, 2025. Its market cap has decreased by -13.24% in one year.
Market Cap
18.44B
Enterprise Value
16.13B
Revenue
10.88B
Ranking
n/a
PE Ratio
13.86
Stock Price
124.50
Market Cap Chart
Since February 19, 1992, Grape King Bio's market cap has increased from 2.32B to 18.44B, an increase of 694.09%. That is a compound annual growth rate of 6.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 18.44B | -16.72% |
| Dec 31, 2024 | 22.15B | -4.17% |
| Dec 29, 2023 | 23.11B | -7.14% |
| Dec 30, 2022 | 24.89B | 5.00% |
| Dec 30, 2021 | 23.70B | -2.02% |
| Dec 31, 2020 | 24.19B | -8.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 252.82B |
| PharmaEssentia | 186.03B |
| Bora Pharmaceuticals Co., LTD. | 77.82B |
| Lotus Pharmaceutical | 74.82B |
| Lumosa Therapeutics | 47.00B |
| Oneness Biotech | 30.13B |
| Polaris Group | 27.85B |
| Center Laboratories | 25.76B |